Company Profile
Accelerate Diagnostics Stock Price, News & Analysis
- Ticker:
- AXDX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
0.03 USD
Close
Last updated: May 14, 2025 at 00:00
—
Market cap
Why the stock is moving
AXDX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Accelerate Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Accelerate Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.
Business Model Characteristics
Accelerate Diagnostics is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.
Position Within the Biotechnology Landscape
Compared with therapeutic biotech names, Accelerate Diagnostics sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties
SPRO · Source: Spero Therapeutics
- 03
- 04
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
ENLV · Source: Enlivex Therapeutics
- 05
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Accelerate Diagnostics (AXDX)?
Accelerate Diagnostics (AXDX) most recently closed at 0.03 USD.
What does Accelerate Diagnostics do?
Accelerate Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
On which exchange is AXDX stock listed?
Accelerate Diagnostics (AXDX) is associated with NASDAQ, United States, Biotechnology.
What is Accelerate?
Accelerate Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Which conditions is Accelerate Diagnostics targeting with Accelerate?
Accelerate Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
What is Diagnostics?
Accelerate Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.